| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
Eric Assaraf
|
Employment |
5
|
1 |
This document is page 26 of a market research report titled 'Cowen Collaborative Insights' dated February 25, 2019. It analyzes the CBD and Hemp industry through the lens of Instagram metrics (followers, posts, likes) for January 2019, comparing emerging brands like CBDFX and Lord Jones against established public companies. While the document bears a 'HOUSE_OVERSIGHT_024842' stamp, suggesting it was part of a document production for a congressional investigation (potentially related to financial probes involving Epstein or Deutsche Bank), the content itself is strictly commercial market analysis with no direct mention of Jeffrey Epstein.
This document is page 25 of a market research report by Cowen Collaborative Insights, dated February 25, 2019. It analyzes the growth of Hemp Oil products on Amazon (increasing from ~5,000 to >20,000 between 2013 and 2019) and provides demographic data on CBD supplement usage based on a January 2019 survey. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional investigation, though the content itself is strictly market data regarding CBD and does not mention Epstein directly.
This document is page 24 of a Cowen Collaborative Insights research report dated February 25, 2019, analyzing the U.S. CBD market. It presents data suggesting the market size is approaching $2 billion based on consumer surveys and increasing Google search trends for CBD products like gummies, creams, and oils. The document bears a House Oversight Bates stamp (024840), indicating it was part of a document production to Congress, though no direct mention of Jeffrey Epstein appears on this specific page.
This document is page 23 of a financial research report produced by Cowen regarding the 'Separations Technology and Market' (Chromatography). It details the technical differences between Liquid Chromatography (LC) and Gas Chromatography (GC), their usage with Mass Spectrometry, and provides market estimates and share data for 2014-2018. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was produced during a congressional investigation, but the text itself contains technical scientific market data and no direct references to Jeffrey Epstein.
This document is page 22 of a Cowen 'Collaborative Insights' market research report dated February 25, 2019, specifically analyzing 'Life Science Tools Participation In The Legal Cannabis Market.' It details the specific scientific technologies (such as Liquid Chromatography and Mass Spectrometry) used for testing cannabis potency and contaminants (pesticides, heavy metals, etc.). The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was produced as part of a congressional investigation, though the text itself contains no direct references to Jeffrey Epstein.
This document is page 21 of a Cowen Collaborative Insights report dated February 25, 2019, analyzing a strategic partnership between Cronos Group and Ginkgo Bioworks valued at $122MM. The text details the financial structure of the deal, including R&D funding and equity milestones for producing specific cannabinoids like THC and CBD. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, likely included in a larger cache of internal financial documents.
This document is page 19 of a Cowen 'Collaborative Insights' report dated February 25, 2019. It details the industry landscape for synthetic biology cannabinoid production, listing specific companies such as Ginkgo Bioworks and Amyris with brief descriptions of their technologies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, though no direct mention of Jeffrey Epstein appears on this specific page.
A page from a Cowen 'Collaborative Insights' financial research report dated February 25, 2019. The document analyzes agricultural economics, specifically comparing corn and soybean margins per acre and detailing the growth of the industrial hemp market in Kentucky under the KDA pilot program. It provides statistical data on acreage, growers, and market shifts toward CBD production between 2014 and 2019. The document bears a House Oversight Bates stamp, suggesting it was part of a document production to Congress.
A page from a Cowen 'Collaborative Insights' report dated February 25, 2019, analyzing the industrial hemp and CBD market. The text details agricultural requirements including soil testing, irrigation, pesticide restrictions, and costs associated with clones versus seeds. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was gathered as part of a congressional investigation, likely into financial practices or specific business entities.
A page from a Cowen Collaborative Insights research report dated February 25, 2019, authored by Neivert. It details the legal status of CBD hemp cultivation following the 2018 Farm Bill, contrasting it with the 2014 Farm Bill, and outlines cultivation practices and the lack of standardized research. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production for a congressional investigation, though the specific content on this page is strictly related to agricultural industry analysis.
This document is page 8 of a Cowen market research report dated February 25, 2019, analyzing the market size and consumer demographics of CBD products. It details survey results from January 2019 showing a 6.9% usage rate, skewing towards younger demographics (18-34), and identifies tinctures as the dominant delivery mechanism. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp (often associated with financial probes into banks connected to Jeffrey Epstein), the content of this specific page is strictly financial market analysis regarding CBD and tobacco/vaping products.
This document is page 7 of a financial research report titled 'Cowen's Collective View of CBD,' dated February 25, 2019. It outlines the anticipated growth of the U.S. CBD market to $16 billion by 2025 and lists various analysts covering specific sectors such as consumer products, pharmacy, and regulation. The document bears a 'HOUSE_OVERSIGHT' stamp, indicating it was likely produced as part of a congressional investigation, possibly related to banking records, though the text itself contains no direct references to Jeffrey Epstein.
This document is the Table of Contents for a 'Cowen Collaborative Insights' research report dated February 25, 2019, focusing on the CBD and Cannabis market. The report covers various sectors including consumer products, healthcare, and global landscapes, with sections attributed to specific analysts (e.g., Azer, Nadeau, Schenkel). The document bears a 'HOUSE_OVERSIGHT_024822' Bates stamp, indicating it is part of a document production to the House Oversight Committee, likely related to investigations into financial records.
This document is page 4 of a Cowen 'Collaborative Insights' market research report dated February 25, 2019. It analyzes the market for cannabinoids (CBD), focusing on synthetic biology production methods, laboratory testing opportunities for life science companies, and the perspectives of drug retailers and insurance payors regarding coverage and sales. The document bears a 'HOUSE_OVERSIGHT_024820' Bates stamp, indicating it was part of a production to the House Oversight Committee, likely related to financial investigations.
A Cowen equity research report titled 'Cowen's Collective View of CBD - Ahead of the Curve Series,' dated February 25, 2019. The document analyzes the U.S. CBD market, projecting a $16 billion opportunity by 2025, and discusses consumer trends, scientific understanding, and hemp cultivation. The document bears a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_024819) and a watermark indicating it was intended for Michael Cella at Cowen.
This document is the cover page of a Cowen Equity Research report titled 'Cowen's Collective View of CBD,' dated February 25, 2019. The report provides market analysis and projections for the CBD industry, predicting $16 billion in sales by 2025, and highlights specific stocks (WEED, TLRY, TPB). While the content is strictly financial research, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024817,' indicating it was collected as part of a House Oversight Committee investigation.
An email dated December 4, 2018, from Kathy Ruemmler to 'jeevacation@gmail.com' (an email alias associated with Jeffrey Epstein). Ruemmler shares an Axios article titled 'Slowing economy could increase pressure on Big Tech' and asks, 'What do we think of this?' The article discusses potential regulatory threats and economic downturns affecting major tech companies like Google and Facebook.
An email exchange from December 4, 2018, between Kathy Ruemmler and 'J' (using the jeevacation@gmail.com alias associated with Jeffrey Epstein). Ruemmler shares an Axios article about regulatory pressure on Big Tech, asking 'What do we think of this?' J replies with a cryptic message offering to 'negotiate am automkoatic reset' that would be 'easy and beneficial for you.' The document bears a House Oversight Bates stamp.
An email exchange from December 4, 2018, between Kathy Ruemmler and 'J' (using the jeevacation@gmail.com alias associated with Jeffrey Epstein). Ruemmler shares an Axios article about regulatory pressure on Big Tech, asking 'What do we think of this?' J replies with a cryptic message offering to 'negotiate am automkoatic reset' that would be 'easy and beneficial for you.' The document bears a House Oversight Bates stamp.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity